We are live on ! Find out more
OBGC

O'Brien Greene & Co Portfolio holdings

AUM $353M
1-Year Est. Return 30.94%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+30.94%
3 Year Est. Return
+79.57%
5 Year Est. Return
+109.64%
10 Year Est. Return
AUM
$274M
AUM Growth
-$5.99M
Cap. Flow
-$1.31M
Cap. Flow %
-0.48%
Top 10 Hldgs %
30.97%
Holding
141
New
5
Increased
67
Reduced
13
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 19.69%
2 Healthcare 14.26%
3 Financials 11.11%
4 Materials 9.37%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URNM icon
76
Sprott Uranium Miners ETF
URNM
$1.79B
$552K 0.2%
+14,370
New +$467K
MDY icon
77
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$540K 0.2%
1,122
TECK icon
78
Teck Resources
TECK
$29.5B
$531K 0.19%
21,300
+550
+3% +$12.6K
SBUX icon
79
Starbucks
SBUX
$118B
$526K 0.19%
4,760
PFE icon
80
Pfizer
PFE
$140B
$517K 0.19%
12,016
ULTA icon
81
Ulta Beauty
ULTA
$20.4B
$505K 0.18%
1,400
AFL icon
82
Aflac
AFL
$63.9B
$504K 0.18%
9,675
-1,400
-13% -$76.5K
TOWN icon
83
Towne Bank
TOWN
$3.35B
$499K 0.18%
16,042
VIG icon
84
Vanguard Dividend Appreciation ETF
VIG
$111B
$490K 0.18%
3,190
-153
-5% -$24.4K
IWN icon
85
iShares Russell 2000 Value ETF
IWN
$14.4B
$461K 0.17%
2,875
SPY icon
86
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$461K 0.17%
1,074
+231
+27% +$102K
NVS icon
87
Novartis
NVS
$295B
$456K 0.17%
5,574
CVS icon
88
CVS Health
CVS
$137B
$454K 0.17%
5,355
+80
+2% +$6.7K
PG icon
89
Procter & Gamble
PG
$343B
$451K 0.16%
3,222
+8
+0.2% +$1.13K
BMY icon
90
Bristol-Myers Squibb
BMY
$127B
$450K 0.16%
7,610
VB icon
91
Vanguard Small-Cap ETF
VB
$79.5B
$432K 0.16%
1,975
PCH
92
DELISTED
PotlatchDeltic
PCH
$426K 0.16%
8,250
+400
+5% +$20.9K
LIN icon
93
Linde
LIN
$237B
$411K 0.15%
1,400
IVV icon
94
iShares Core S&P 500 ETF
IVV
$869B
$408K 0.15%
946
-116
-11% -$51.4K
MRK icon
95
Merck
MRK
$324B
$408K 0.15%
5,435
-10
-0.2% -$761
DEO icon
96
Diageo
DEO
$46.2B
$400K 0.15%
2,070
+65
+3% +$12.6K
BTI icon
97
British American Tobacco
BTI
$132B
$390K 0.14%
11,065
-6,004
-35% -$225K
AMT icon
98
American Tower
AMT
$77.7B
$385K 0.14%
1,450
+50
+4% +$14.3K
FMX icon
99
Fomento Económico Mexicano
FMX
$43.3B
$372K 0.14%
4,289
+334
+8% +$28.7K
WMB icon
100
Williams Companies
WMB
$90.5B
$362K 0.13%
13,950
+900
+7% +$22.7K

Similar funds

O'Brien Greene & Co's Q3 2021 Portfolio in Review

As of Q3 2021, O'Brien Greene & Co held 141 positions worth $274M, down 2.1% from $280M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

O'Brien Greene & Co's Q3 2021 filing shows 5 new, 67 increased, 13 reduced and 8 closed positions. Its largest new stake was PLx Pharma Inc. Common Stock: 62,340 shares worth $1.2M. The largest sale was Dollar Tree, an estimated $5.63M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • O'Brien Greene & Co's largest Q3 2021 buy was PLx Pharma Inc. Common Stock: 62,340 shares worth $1.2M.
  • O'Brien Greene & Co added most to Medtronic in Q3 2021, an estimated $4.34M increase.
  • O'Brien Greene & Co's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $4.54M.
  • O'Brien Greene & Co fully exited Dollar Tree in Q3 2021, selling an estimated $5.63M.
  • O'Brien Greene & Co's ten largest holdings make up 31% of its $274M portfolio in Q3 2021.
  • O'Brien Greene & Co opened 5 new positions and closed 8 in Q3 2021.
  • O'Brien Greene & Co's portfolio value fell 2.1% quarter-over-quarter to $274M.

Based on O'Brien Greene & Co's 13F filing for Q3 2021, filed 12 Nov 2021.